|
1
|
United Nations. World Population Ageing.
New York, USA: 2009
|
|
2
|
World Health Report. World Health
Organization; Geneva: 2002
|
|
3
|
Santos LL, Cavalcanti TB and Bandeira FA:
Vascular effects of bisphosphonates - a systematic review. Clin Med
Insights Endocrinol Diabetes. 5:47–54. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lampropoulos CE, Papaioannou I and D’Cruz
DP: Osteoporosis - a risk factor for cardiovascular disease? Nat
Rev Rheumatol. 8:587–598. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Perrini S, Natalicchio A, Laviola L, et
al: Abnormalities of insulin-like growth factor-I signaling and
impaired cell proliferation in osteoblasts from subjects with
osteoporosis. Endocrinology. 149:1302–1313. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mithal A: Osteoporosis in Asia: a call to
action. Osteoporos Int. 23:S739–S740. 2012.
|
|
7
|
Yesil Y, Ulger Z, Halil M, et al:
Coexistence of osteoporosis (OP) and coronary artery disease (CAD)
in the elderly: It is not just a by chance event. Arch Gerontol
Geriatr. 54:473–476. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rhee EJ, Lee WY, Kim SY, et al:
Relationship of serum osteoprotegerin levels with coronary artery
disease severity, left ventricular hypertrophy and C-reactive
protein. Clin Sci (Lond). 108:237–243. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vattikuti R and Towler DA: Osteogenic
regulation of vascular calcification: an early perspective. Am J
Physiol Endocrinol Metab. 286:E686–E696. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Giachelli CM: Vascular calcification
mechanisms. J Am Soc Nephrol. 15:2959–2964. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hofbauer LC, Brueck CC, Shanahan CM,
Schoppet M and Dobnig H: Vascular calcification and osteoporosis -
from clinical observation towards molecular understanding.
Osteoporos Int. 18:251–259. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Price PA, Faus SA and Williamson MK:
Bisphosphonates alendronate and ibandronate inhibit artery
calcification at doses comparable to those that inhibit bone
resorption. Arterioscler Thromb Vasc Biol. 21:817–824. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Skolnick AH, Osranek M, Formica P and
Kronzon I: Osteoporosis treatment and progression of aortic
stenosis. Am J Cardiol. 104:122–124. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ylitalo R, Kalliovalkama J, Wu XM, et al:
Accumulation of bisphosphonates in human artery and their effects
on human and rat arterial function in vitro. Pharmacol Toxicol.
83:125–131. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
London GM: Bone-vascular cross-talk. J
Nephrol. 25:619–625. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Boanini E, Torricelli P, Gazzano M, Fini M
and Bigi A: The effect of alendronate doped calcium phosphates on
bone cells activity. Bone. 51:944–952. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Keam SJ and Plosker GL: Prevention and
treatment of osteoporosis in postmenopausal women. Dis Manag Health
Outcome. 12:19–37. 2004. View Article : Google Scholar
|
|
18
|
Iwamoto J, Takeda T, Sato Y and Uzawa M:
Effects of alendronate on metacarpal and lumbar bone mineral
density, bone resorption, and chronic back pain in postmenopausal
women with osteoporosis. Clin Rheumatol. 23:383–389. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Manderfield LJ, High FA, Engleka KA, et
al: Notch activation of Jagged1 contributes to the assembly of the
arterial wall. Circulation. 125:314–323. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kurpinski K, Lam H, Chu JL, et al:
Transforming growth factor-beta and notch signaling mediate stem
cell differentiation into smooth muscle cells. Stem Cells.
28:734–742. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Morimoto M, Liu ZY, Cheng HT, Winters N,
Bader D and Kopan R: Canonical Notch signaling in the developing
lung is required for determination of arterial smooth muscle cells
and selection of Clara versus ciliated cell fate. J Cell Sci.
123:213–224. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shimizu T, Tanaka T, Iso T, et al: Notch
signaling induces osteogenic differentiation and mineralization of
vascular smooth muscle cells: role of Msx2 gene induction via
Notch-RBP-Jk signaling. Arterioscler Thromb Vasc Biol.
29:1104–1111. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Morrow D, Guha S, Sweeney C, et al: Notch
and vascular smooth muscle cell phenotype. Circ Res. 103:1370–1382.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Iyemere VP, Proudfoot D, Weissberg PL and
Shanahan CM: Vascular smooth muscle cell phenotypic plasticity and
the regulation of vascular calcification. J Intern Med.
260:192–210. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sage AP, Tintut Y and Demer LL: Regulatory
mechanisms in vascular calcification. Nat Rev Cardiol. 7:528–536.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang M, Wu L, Wang L and Xin X:
Down-regulation of Notch1 by gamma-secretase inhibition contributes
to cell growth inhibition and apoptosis in ovarian cancer cells
A2780. Biochem Biophys Res Commun. 393:144–149. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Price PA, June HH, Buckley JR and
Williamson MK: Osteoprotegerin inhibits artery calcification
induced by warfarin and by vitamin D. Arterioscler Thromb Vasc
Biol. 21:1610–1616. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xin H, Xin F, Zhou S and Guan S: The
Wnt5a/Ror2 pathway is associated with determination of the
differentiation fate of bone marrow mesenchymal stem cells in
vascular calcification. Int J Mol Med. 31:583–588. 2013.PubMed/NCBI
|
|
29
|
Zuo C, Huang Y, Bajis R, et al:
Osteoblastogenesis regulation signals in bone remodeling.
Osteoporos Int. 23:1653–1663. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zanotti S and Canalis E: Notch signaling
and bone. IBMS BoneKEy. 8:318–327. 2011. View Article : Google Scholar
|
|
31
|
Doi H, Iso T, Shiba Y, et al: Notch
signaling regulates the differentiation of bone marrow-derived
cells into smooth muscle-like cells during arterial lesion
formation. Biochem Biophys Res Commun. 381:654–659. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Engin FZ, Yao ZQ, Yang T, et al: Dimorphic
effects of Notch signaling in bone homeostasis. Nat Med.
14:299–305. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Maeda K, Kobayashi Y, Udagawa N, et al:
Wnt5a-Ror2 signaling between osteoblast-lineage cells and
osteoclast precursors enhances osteoclastogenesis. Nat Med.
18:405–412. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Al-Aly Z: Arterial calcification: a tumor
necrosis factor-alpha mediated vascular Wnt-opothy. Transl Res.
151:233–239. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nie B, Zhou S, Fang X, Li W, Wang B and
Guan S: Implication of receptor activator of NF-kappaB ligand in
Wnt/beta-catenin pathway promoting osteoblast-like cell
differentiation. J Huazhong Univ Sci Technolog Med Sci. 32:818–822.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Iso T, Hamamori Y and Kedes L: Notch
signaling in vascular development. Arterioscler Thromb Vasc Biol.
23:543–553. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Morrow D, Scheller A, Birney YA, et al:
Notch-mediated CBF-1/RBP-J{kappa}-dependent regulation of human
vascular smooth muscle cell phenotype in vitro. Am J Physiol Cell
Physiol. 289:C1188–C1196. 2005.
|
|
38
|
Shimizu T, Tanaka T, Iso T and Kurabayashi
M: Notch signaling directly targets Msx2: possible role of notch
signaling in osteogenic conversion of vascular smooth muscle cells
and vascular calcification. Circulation. 118:S3682008.
|
